Chemical ID |
Chemical Name |
Interaction |
Interaction Action |
Publication |
---|
C028474 |
1,4-bis(2-(3,5-dichloropyridyloxy))benzene |
1,4-bis(2-(3,5-dichloropyridyloxy))benzene results in decreased expression of ACAA1 mRNA | decreases expression | 18281256
|
C028474 |
1,4-bis(2-(3,5-dichloropyridyloxy))benzene |
NR1I3 protein promotes the reaction [1,4-bis(2-(3,5-dichloropyridyloxy))benzene results in decreased expression of ACAA1 mRNA] | decreases expression|increases reaction | 18281256
|
C031903 |
1-UFT protocol |
ACAA1 protein results in increased susceptibility to 1-UFT protocol | increases response to substance | 16734730
|
C023514 |
2,6-dinitrotoluene |
2,6-dinitrotoluene affects the expression of ACAA1 mRNA | affects expression | 21346803
|
C035207 |
4-amino-2,6-dinitrotoluene |
4-amino-2,6-dinitrotoluene affects the expression of ACAA1 mRNA | affects expression | 21346803
|
D000082 |
Acetaminophen |
Acetaminophen results in decreased expression of ACAA1 mRNA | decreases expression | 15084756
|
D016604 |
Aflatoxin B1 |
Aflatoxin B1 affects the expression of ACAA1 protein | affects expression | 20106945
|
D000638 |
Amiodarone |
Amiodarone results in increased expression of ACAA1 mRNA | increases expression | 15265979
|
D002104 |
Cadmium |
Cadmium results in increased expression of ACAA1 mRNA | increases expression | 17327699
|
D019256 |
Cadmium Chloride |
Cadmium Chloride results in increased expression of ACAA1 mRNA | increases expression | 17327699
|
C110904 |
capecitabine |
ACAA1 protein results in increased susceptibility to capecitabine | increases response to substance | 16734730
|
C030123 |
coumarin |
coumarin results in increased expression of ACAA1 mRNA | increases expression | 18480146
|
D016572 |
Cyclosporine |
Cyclosporine results in decreased expression of ACAA1 mRNA | decreases expression | 20106945
|
D004041 |
Dietary Fats |
Dietary Fats results in increased expression of ACAA1 mRNA | increases expression | 18457598 16357043
|
C025034 |
doxifluridine |
ACAA1 protein results in increased susceptibility to doxifluridine | increases response to substance | 16734730
|
C039281 |
furan |
furan results in decreased expression of ACAA1 mRNA | decreases expression | 15120968
|
D006830 |
Hydralazine |
[Hydralazine co-treated with Valproic Acid] results in increased expression of ACAA1 mRNA | affects cotreatment|increases expression | 17183730
|
D008701 |
Methapyrilene |
Methapyrilene results in decreased expression of ACAA1 mRNA | decreases expression | 15120968
|
D008727 |
Methotrexate |
Methotrexate results in decreased expression of ACAA1 mRNA | decreases expression | 15120968
|
C076994 |
perfluorooctane sulfonic acid |
perfluorooctane sulfonic acid results in increased expression of ACAA1 mRNA | increases expression | 16221955
|
C023036 |
perfluorooctanoic acid |
perfluorooctanoic acid affects the expression of ACAA1 mRNA | affects expression | 18281256
|
C023036 |
perfluorooctanoic acid |
perfluorooctanoic acid results in increased expression of ACAA1 mRNA | increases expression | 18467677
|
C023036 |
perfluorooctanoic acid |
PPARA protein promotes the reaction [perfluorooctanoic acid results in increased expression of ACAA1 mRNA] | increases expression|increases reaction | 18467677
|
C023036 |
perfluorooctanoic acid |
perfluorooctanoic acid results in increased expression of ACAA1 mRNA | increases expression | 16221955
|
D010795 |
Phthalic Acids |
Phthalic Acids results in decreased expression of ACAA1 mRNA | decreases expression | 15728792
|
C006253 |
pirinixic acid |
pirinixic acid results in increased expression of ACAA1 mRNA | increases expression | 16357043 15375163 18467677
|
C006253 |
pirinixic acid |
pirinixic acid results in increased expression of ACAA1 protein | increases expression | 15226431
|
C006253 |
pirinixic acid |
PPARA protein promotes the reaction [pirinixic acid results in increased expression of ACAA1 mRNA] | increases expression|increases reaction | 18467677
|
C006253 |
pirinixic acid |
pirinixic acid results in increased expression of ACAA1 mRNA | increases expression | 16940010
|
D011794 |
Quercetin |
Quercetin results in decreased expression of ACAA1 mRNA | decreases expression | 16455785
|
C079198 |
S 1 (combination) |
ACAA1 protein results in increased susceptibility to S 1 (combination) | increases response to substance | 16734730
|
D013749 |
Tetrachlorodibenzodioxin |
Tetrachlorodibenzodioxin results in increased expression of ACAA1 mRNA | increases expression | 16054898 16960034
|
D014303 |
Trinitrotoluene |
Trinitrotoluene affects the expression of ACAA1 mRNA | affects expression | 21346803
|
D014635 |
Valproic Acid |
[Hydralazine co-treated with Valproic Acid] results in increased expression of ACAA1 mRNA | affects cotreatment|increases expression | 17183730
|
Disease ID |
Disease Name |
Direct Evidence |
Inference Chemical Name |
Inference Score |
Publication |
---|
MESH:D000014 |
Abnormalities, Drug-Induced |
|
4-amino-2,6-dinitrotoluene |
24.25 | 7525203 |
MESH:D000014 |
Abnormalities, Drug-Induced |
|
Methotrexate |
24.25 | 12039119 |
MESH:D000014 |
Abnormalities, Drug-Induced |
|
Tetrachlorodibenzodioxin |
24.25 | 15322242 11752688 14514962 |
MESH:D000014 |
Abnormalities, Drug-Induced |
|
Trinitrotoluene |
24.25 | 7525203 |
MESH:D000014 |
Abnormalities, Drug-Induced |
|
Valproic Acid |
24.25 | 8875741 |
MESH:D000015 |
Abnormalities, Multiple |
|
Valproic Acid |
3.72 | 19490988 |
MESH:D055371 |
Acute Lung Injury |
|
pirinixic acid |
2.91 | 18653653 |
MESH:D018248 |
Adenoma, Liver Cell |
|
pirinixic acid |
9.14 | 16434500 |
MESH:D018248 |
Adenoma, Liver Cell |
|
Tetrachlorodibenzodioxin |
9.14 | 16835633 |
MESH:D000550 |
Amblyopia |
|
Valproic Acid |
5.00 | 17688650 |
MESH:D000740 |
Anemia |
|
Tetrachlorodibenzodioxin |
2.75 | 11748828 |
MESH:D000743 |
Anemia, Hemolytic |
|
Quercetin |
4.03 | 17084956 |
MESH:D000799 |
Angioedema |
|
Acetaminophen |
3.61 | 10982225 |
MESH:D001008 |
Anxiety Disorders |
|
Valproic Acid |
3.39 | 17497229 |
MESH:D001145 |
Arrhythmias, Cardiac |
|
Amiodarone |
3.60 | 20041841 18218290 18057881 |
MESH:D001161 |
Arteriosclerosis |
|
Dietary Fats |
3.66 | 15238619 |
MESH:D001172 |
Arthritis, Rheumatoid |
|
Methotrexate |
3.05 | 17286800 |
MESH:D001260 |
Ataxia Telangiectasia |
|
Quercetin |
4.75 | 15336622 |
MESH:D050197 |
Atherosclerosis |
|
Cadmium |
3.51 | 15687053 |
MESH:D001281 |
Atrial Fibrillation |
|
Amiodarone |
3.73 | 19698954 18651412 |
MESH:D001289 |
Attention Deficit Disorder with Hyperactivity |
|
Phthalic Acids |
4.21 | 20106747 |
MESH:D001321 |
Autistic Disorder |
|
Acetaminophen |
1.85 | 18445737 |
MESH:D001321 |
Autistic Disorder |
|
Valproic Acid |
1.85 | 18316065 16609825 17157402 18775368 17507914 18396377 20603192 18558336 15238991 19460635 18940202 17688650 18985861 18177632 19232924 |
MESH:D001327 |
Autoimmune Diseases |
|
Quercetin |
4.18 | 19761891 |
MESH:D001714 |
Bipolar Disorder |
|
Valproic Acid |
2.96 | 17594078 20046352 |
MESH:D001778 |
Blood Coagulation Disorders |
|
Amiodarone |
14.12 | 19483382 |
MESH:D001778 |
Blood Coagulation Disorders |
|
pirinixic acid |
14.12 | 19483382 |
MESH:D001778 |
Blood Coagulation Disorders |
|
Tetrachlorodibenzodioxin |
14.12 | 12125929 |
MESH:D001836 |
Body Weight Changes |
|
Tetrachlorodibenzodioxin |
3.56 | 15340226 |
MESH:D001848 |
Bone Diseases, Developmental |
|
Tetrachlorodibenzodioxin |
7.54 | 15746008 |
MESH:D001848 |
Bone Diseases, Developmental |
|
Valproic Acid |
7.54 | 8888407 |
MESH:D001943 |
Breast Neoplasms |
|
capecitabine |
2.30 | 12972520 18473752 |
MESH:D001943 |
Breast Neoplasms |
|
Dietary Fats |
2.30 | 20435547 |
MESH:D001943 |
Breast Neoplasms |
|
Methotrexate |
2.30 | 16978400 |
MESH:D001943 |
Breast Neoplasms |
|
Quercetin |
2.30 | 18628248 |
MESH:D001943 |
Breast Neoplasms |
|
Tetrachlorodibenzodioxin |
2.30 | 20435547 |
MESH:D002105 |
Cadmium Poisoning |
|
Quercetin |
5.31 | 16962696 |
MESH:D002277 |
Carcinoma |
|
Tetrachlorodibenzodioxin |
2.62 | 16835633 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
2,6-dinitrotoluene |
6.26 | 16705839 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
Acetaminophen |
6.26 | 3084413 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
Aflatoxin B1 |
6.26 | 21507988 12619106 12907637 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
Quercetin |
6.26 | 19519916 12508355 |
MESH:D002289 |
Carcinoma, Non-Small-Cell Lung |
|
S 1 (combination) |
3.99 | 18212800 18347146 |
MESH:D021441 |
Carcinoma, Pancreatic Ductal |
|
Quercetin |
4.73 | 17234771 |
MESH:D002294 |
Carcinoma, Squamous Cell |
|
S 1 (combination) |
3.79 | 15984520 |
MESH:D006332 |
Cardiomegaly |
|
Quercetin |
6.39 | 19794523 |
MESH:D006332 |
Cardiomegaly |
|
Tetrachlorodibenzodioxin |
6.39 | 18670907 18850075 16120746 |
MESH:D002311 |
Cardiomyopathy, Dilated |
|
Amiodarone |
2.82 | 15710769 19225199 |
MESH:D002341 |
Carotid Artery Thrombosis |
|
Amiodarone |
4.85 | 18974383 |
MESH:D002386 |
Cataract |
|
4-amino-2,6-dinitrotoluene |
11.71 | 14694615 |
MESH:D002386 |
Cataract |
|
Acetaminophen |
11.71 | 10977129 |
MESH:D002386 |
Cataract |
|
Trinitrotoluene |
11.71 | 15817613 14694615 |
MESH:D002471 |
Cell Transformation, Neoplastic |
|
2,6-dinitrotoluene |
10.37 | 6135515 |
MESH:D002471 |
Cell Transformation, Neoplastic |
|
Cadmium |
10.37 | 17332340 |
MESH:D002471 |
Cell Transformation, Neoplastic |
|
Cyclosporine |
10.37 | 12371664 |
MESH:D002659 |
Child Development Disorders, Pervasive |
|
Valproic Acid |
2.63 | 20734317 |
MESH:D018281 |
Cholangiocarcinoma |
|
Tetrachlorodibenzodioxin |
2.97 | 16835633 |
MESH:D002779 |
Cholestasis |
|
Cyclosporine |
7.20 | 19486331 |
MESH:D002779 |
Cholestasis |
|
pirinixic acid |
7.20 | 19176532 |
MESH:D002972 |
Cleft Palate |
|
Tetrachlorodibenzodioxin |
2.01 | 16354765 15668235 15340226 12621046 8697196 |
MESH:D003110 |
Colonic Neoplasms |
|
Quercetin |
2.38 | 17191121 11134977 19056647 17148506 16640504 19440933 15741050 |
MESH:D015179 |
Colorectal Neoplasms |
|
capecitabine |
3.09 | 18448328 18473752 |
MESH:D015179 |
Colorectal Neoplasms |
|
Quercetin |
3.09 | 18852136 18095365 |
MESH:D000013 |
Congenital Abnormalities |
|
4-amino-2,6-dinitrotoluene |
14.50 | 15095906 |
MESH:D000013 |
Congenital Abnormalities |
|
Tetrachlorodibenzodioxin |
14.50 | 14669216 17141729 |
MESH:D000013 |
Congenital Abnormalities |
|
Trinitrotoluene |
14.50 | 15095906 |
MESH:D003329 |
Coronary Vasospasm |
|
capecitabine |
5.59 | 17465463 |
MESH:D019465 |
Craniofacial Abnormalities |
|
Methotrexate |
3.73 | 9562676 12039119 |
MESH:D019465 |
Craniofacial Abnormalities |
|
Tetrachlorodibenzodioxin |
3.73 | 20055451 10048152 15322242 |
MESH:D019465 |
Craniofacial Abnormalities |
|
Valproic Acid |
3.73 | 17688650 16575769 8888407 |
MESH:D003490 |
Cyanosis |
|
2,6-dinitrotoluene |
10.48 | 18551238 |
MESH:D003490 |
Cyanosis |
|
Trinitrotoluene |
10.48 | 18551238 |
MESH:D003550 |
Cystic Fibrosis |
|
Methotrexate |
4.04 | 19747007 |
MESH:D003876 |
Dermatitis, Atopic |
|
pirinixic acid |
2.32 | 18249437 |
MESH:D003882 |
Dermatomyositis |
|
Methotrexate |
4.91 | 20191521 |
MESH:D003921 |
Diabetes Mellitus, Experimental |
|
Quercetin |
3.55 | 19496084 |
MESH:D003924 |
Diabetes Mellitus, Type 2 |
|
coumarin |
4.40 | 19647726 |
MESH:D003924 |
Diabetes Mellitus, Type 2 |
|
Tetrachlorodibenzodioxin |
4.40 | 17107852 |
MESH:D056486 |
Drug-Induced Liver Injury |
|
2,6-dinitrotoluene |
17.61 | 21346803 18551238 |
MESH:D056486 |
Drug-Induced Liver Injury |
|
4-amino-2,6-dinitrotoluene |
17.61 | 21346803 |
MESH:D056486 |
Drug-Induced Liver Injury |
|
Acetaminophen |
17.61 | 14550746 16109766 18713872 16227642 16393943 17906064 19416960 16081117 16781746 11287661 17562736 19739265 10663392 16177239 12705907 14986274 11461765 10915739 11739529 19085960 14725611 11834606 12153990 12958197 11529661 10774834 18071297 19923254 16485898 19164858 19370779 11421492 11743745 15968718 12540782 12594235 19420014 17522070 12392966 15619225 2444490 |
MESH:D056486 |
Drug-Induced Liver Injury |
|
Amiodarone |
17.61 | 18218290 15265979 |
MESH:D056486 |
Drug-Induced Liver Injury |
|
Tetrachlorodibenzodioxin |
17.61 | 20420201 |
MESH:D056486 |
Drug-Induced Liver Injury |
|
Trinitrotoluene |
17.61 | 18551238 21346803 |
MESH:D056486 |
Drug-Induced Liver Injury |
|
Valproic Acid |
17.61 | 1733752 19641884 |
MESH:D056487 |
Drug-Induced Liver Injury, Chronic |
|
Acetaminophen |
3.87 | 19426721 |
MESH:D004362 |
Drug Toxicity |
|
Tetrachlorodibenzodioxin |
2.59 | 11462148 |
MESH:D050171 |
Dyslipidemias |
|
Dietary Fats |
3.29 | 18367378 |
MESH:D004421 |
Dystonia |
|
Valproic Acid |
3.84 | 1851702 |
MESH:D004487 |
Edema |
|
perfluorooctanoic acid |
10.28 | 12083418 17259670 |
MESH:D004487 |
Edema |
|
pirinixic acid |
10.28 | 12083418 |
MESH:D004487 |
Edema |
|
Tetrachlorodibenzodioxin |
10.28 | 12711302 11000095 |
MESH:D004489 |
Edema, Cardiac |
|
Tetrachlorodibenzodioxin |
3.67 | 18230668 16714409 15322242 |
MESH:D004715 |
Endometriosis |
|
Tetrachlorodibenzodioxin |
2.82 | 9294722 10568697 |
MESH:D004831 |
Epilepsies, Myoclonic |
|
Valproic Acid |
3.93 | 17275665 3659116 |
MESH:D004828 |
Epilepsies, Partial |
|
Valproic Acid |
3.69 | 3922381 16628512 |
MESH:D004827 |
Epilepsy |
|
Valproic Acid |
2.82 | 20417680 18234410 |
MESH:D004832 |
Epilepsy, Absence |
|
Valproic Acid |
3.40 | 6426943 7562514 6254150 |
MESH:D017029 |
Epilepsy, Complex Partial |
|
Valproic Acid |
4.07 | 7750514 |
MESH:D004830 |
Epilepsy, Tonic-Clonic |
|
Valproic Acid |
3.84 | 3659116 |
MESH:D005124 |
Eye Abnormalities |
|
Tetrachlorodibenzodioxin |
2.84 | 11564622 |
MESH:D005234 |
Fatty Liver |
|
Amiodarone |
22.47 | 14986274 |
MESH:D005234 |
Fatty Liver |
|
Cyclosporine |
22.47 | 19224547 |
MESH:D005234 |
Fatty Liver |
|
Dietary Fats |
22.47 | 17967931 19551842 18296743 19004024 |
MESH:D005234 |
Fatty Liver |
|
pirinixic acid |
22.47 | 20131406 19236843 |
MESH:D005234 |
Fatty Liver |
|
Valproic Acid |
22.47 | 14986274 19224547 |
MESH:D005313 |
Fetal Death |
|
Tetrachlorodibenzodioxin |
3.23 | 11858732 |
MESH:D005315 |
Fetal Diseases |
|
Valproic Acid |
4.66 | 16575769 |
MESH:D005317 |
Fetal Growth Retardation |
|
Valproic Acid |
3.91 | 8888407 18558336 |
MESH:D005355 |
Fibrosis |
|
Cyclosporine |
19.30 | 12168785 12639820 |
MESH:D005355 |
Fibrosis |
|
Dietary Fats |
19.30 | 18296743 |
MESH:D005355 |
Fibrosis |
|
Quercetin |
19.30 | 19474275 |
MESH:D005355 |
Fibrosis |
|
Tetrachlorodibenzodioxin |
19.30 | 20067830 |
MESH:D005706 |
Gallbladder Neoplasms |
|
S 1 (combination) |
5.54 | 19093184 |
MESH:D005756 |
Gastritis |
|
Acetaminophen |
3.44 | 16983495 |
MESH:D005885 |
Gingival Hyperplasia |
|
Cyclosporine |
3.99 | 8708960 |
MESH:D005909 |
Glioblastoma |
|
perfluorooctane sulfonic acid |
7.23 | 17162496 |
MESH:D005909 |
Glioblastoma |
|
Quercetin |
7.23 | 19804834 |
MESH:D005910 |
Glioma |
|
Quercetin |
2.97 | 17643826 |
MESH:D006058 |
Gonadal Disorders |
|
Tetrachlorodibenzodioxin |
4.36 | 10696789 |
MESH:D006086 |
Graft vs Host Disease |
|
Methotrexate |
4.92 | 16518429 |
MESH:D006258 |
Head and Neck Neoplasms |
|
S 1 (combination) |
4.60 | 15984520 18607998 |
MESH:D006330 |
Heart Defects, Congenital |
|
Tetrachlorodibenzodioxin |
2.21 | 10048152 11294989 |
MESH:D006333 |
Heart Failure |
|
pirinixic acid |
2.40 | 20558911 |
MESH:D006457 |
Hemoglobinuria, Paroxysmal |
|
Cyclosporine |
4.19 | 15720958 |
MESH:D006470 |
Hemorrhage |
|
Tetrachlorodibenzodioxin |
3.13 | 11000095 |
MESH:D006529 |
Hepatomegaly |
|
1,4-bis(2-(3,5-dichloropyridyloxy))benzene |
30.85 | 16109766 |
MESH:D006529 |
Hepatomegaly |
|
Amiodarone |
30.85 | 15265979 |
MESH:D006529 |
Hepatomegaly |
|
perfluorooctanoic acid |
30.85 | 3609246 |
MESH:D006529 |
Hepatomegaly |
|
pirinixic acid |
30.85 | 16221962 18467677 19772884 19176532 |
MESH:D006529 |
Hepatomegaly |
|
Tetrachlorodibenzodioxin |
30.85 | 15340226 12621046 16120746 |
MESH:D006529 |
Hepatomegaly |
|
Trinitrotoluene |
30.85 | 15817613 |
MESH:D006849 |
Hydrocephalus |
|
Valproic Acid |
4.64 | 17688650 |
MESH:D006869 |
Hydronephrosis |
|
Tetrachlorodibenzodioxin |
3.81 | 18606429 16354765 8697196 16959395 15340226 |
MESH:D006930 |
Hyperalgesia |
|
Acetaminophen |
7.27 | 16870215 |
MESH:D006930 |
Hyperalgesia |
|
perfluorooctanoic acid |
7.27 | 12083418 |
MESH:D006937 |
Hypercholesterolemia |
|
Amiodarone |
8.48 | 9751232 8137927 |
MESH:D006937 |
Hypercholesterolemia |
|
Dietary Fats |
8.48 | 21332399 |
MESH:D006943 |
Hyperglycemia |
|
pirinixic acid |
8.58 | 20558911 |
MESH:D006943 |
Hyperglycemia |
|
Quercetin |
8.58 | 11834736 18262572 |
MESH:D006949 |
Hyperlipidemias |
|
Dietary Fats |
3.40 | 21332399 |
MESH:D006973 |
Hypertension |
|
Cyclosporine |
8.07 | 10903974 |
MESH:D006973 |
Hypertension |
|
Quercetin |
8.07 | 18356687 |
MESH:D006973 |
Hypertension |
|
Tetrachlorodibenzodioxin |
8.07 | 18850075 18670907 |
MESH:D046110 |
Hypertension, Pregnancy-Induced |
|
Hydralazine |
4.40 | 16612254 |
MESH:D007037 |
Hypothyroidism |
|
Amiodarone |
4.29 | 17991464 18020914 |
MESH:D007248 |
Infertility, Male |
|
Trinitrotoluene |
3.53 | 12150543 |
MESH:D007249 |
Inflammation |
|
Dietary Fats |
7.68 | 20412841 |
MESH:D007249 |
Inflammation |
|
perfluorooctanoic acid |
7.68 | 12083418 |
MESH:D007249 |
Inflammation |
|
Tetrachlorodibenzodioxin |
7.68 | 12878042 12200463 |
MESH:D007251 |
Influenza, Human |
|
Quercetin |
4.28 | 16624496 |
MESH:D007333 |
Insulin Resistance |
|
Dietary Fats |
6.76 | 11836018 18457598 |
MESH:D007333 |
Insulin Resistance |
|
pirinixic acid |
6.76 | 16306350 |
MESH:D007569 |
Jaw Abnormalities |
|
Tetrachlorodibenzodioxin |
3.13 | 16580747 |
MESH:D007627 |
Keloid |
|
Quercetin |
4.73 | 17086741 |
MESH:D007638 |
Keratoconjunctivitis Sicca |
|
Cyclosporine |
4.21 | 15604871 |
MESH:D007674 |
Kidney Diseases |
|
Acetaminophen |
17.69 | 12587719 15629191 |
MESH:D007674 |
Kidney Diseases |
|
Cadmium |
17.69 | 16962696 16322080 16226777 |
MESH:D007674 |
Kidney Diseases |
|
Cadmium Chloride |
17.69 | 16962696 |
MESH:D007674 |
Kidney Diseases |
|
Cyclosporine |
17.69 | 8314463 18776723 10903974 |
MESH:D007674 |
Kidney Diseases |
|
Quercetin |
17.69 | 16962696 |
MESH:D007680 |
Kidney Neoplasms |
|
2,6-dinitrotoluene |
6.66 | 16705839 |
MESH:D007680 |
Kidney Neoplasms |
|
Cyclosporine |
6.66 | 12371664 |
MESH:D007805 |
Language Development Disorders |
|
Methotrexate |
4.89 | 9562676 |
MESH:D007938 |
Leukemia |
|
Quercetin |
3.04 | 17468513 |
MESH:D015470 |
Leukemia, Myeloid, Acute |
|
Valproic Acid |
2.11 | 17596541 16294345 |
MESH:D007984 |
Leydig Cell Tumor |
|
perfluorooctanoic acid |
5.00 | 8812269 |
MESH:D008064 |
Lipidoses |
|
Amiodarone |
3.35 | 17567588 15342952 |
MESH:D008103 |
Liver Cirrhosis |
|
Dietary Fats |
6.54 | 18296743 |
MESH:D008103 |
Liver Cirrhosis |
|
Methotrexate |
6.54 | 14986274 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
pirinixic acid |
3.29 | 15474484 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
Quercetin |
3.29 | 12741479 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
Tetrachlorodibenzodioxin |
3.29 | 12878042 |
MESH:D008107 |
Liver Diseases |
|
Acetaminophen |
1.58 | 11587558 16611625 12587719 19784758 19460945 12969438 16610002 19014921 |
MESH:D017114 |
Liver Failure, Acute |
|
Acetaminophen |
3.04 | 17185352 16871587 |
MESH:D008113 |
Liver Neoplasms |
|
2,6-dinitrotoluene |
20.56 | 7678174 |
MESH:D008113 |
Liver Neoplasms |
|
Aflatoxin B1 |
20.56 | 2125692 15890375 18177683 9163691 |
MESH:D008113 |
Liver Neoplasms |
|
Methapyrilene |
20.56 | 15890375 |
MESH:D008113 |
Liver Neoplasms |
|
perfluorooctanoic acid |
20.56 | 18709148 14757943 |
MESH:D008113 |
Liver Neoplasms |
|
pirinixic acid |
20.56 | 16377806 20007298 15890375 |
MESH:D008113 |
Liver Neoplasms |
|
Quercetin |
20.56 | 18980244 |
MESH:D008113 |
Liver Neoplasms |
|
Tetrachlorodibenzodioxin |
20.56 | 16984957 |
MESH:D008114 |
Liver Neoplasms, Experimental |
|
2,6-dinitrotoluene |
12.97 | 2876784 2876786 6135515 |
MESH:D008114 |
Liver Neoplasms, Experimental |
|
Aflatoxin B1 |
12.97 | 8603461 |
MESH:D008114 |
Liver Neoplasms, Experimental |
|
Quercetin |
12.97 | 19519916 |
MESH:D008114 |
Liver Neoplasms, Experimental |
|
Tetrachlorodibenzodioxin |
12.97 | 12151625 |
MESH:D008133 |
Long QT Syndrome |
|
Amiodarone |
3.41 | 15350150 11989578 17391786 |
MESH:D008171 |
Lung Diseases |
|
Amiodarone |
3.22 | 12587719 |
MESH:D017563 |
Lung Diseases, Interstitial |
|
Amiodarone |
17.80 | 18516814 |
MESH:D017563 |
Lung Diseases, Interstitial |
|
Methotrexate |
17.80 | 18516814 |
MESH:D017563 |
Lung Diseases, Interstitial |
|
Valproic Acid |
17.80 | 17228818 |
MESH:D008175 |
Lung Neoplasms |
|
Aflatoxin B1 |
3.29 | 14755239 |
MESH:D008175 |
Lung Neoplasms |
|
Quercetin |
3.29 | 16280456 |
MESH:D008175 |
Lung Neoplasms |
|
Tetrachlorodibenzodioxin |
3.29 | 19555203 11884234 |
MESH:D008223 |
Lymphoma |
|
Methotrexate |
3.79 | 17352296 |
MESH:D008546 |
Melanoma, Experimental |
|
Acetaminophen |
3.34 | 19513568 |
MESH:D008664 |
Metal Metabolism, Inborn Errors |
|
Cyclosporine |
4.56 | 16801185 |
MESH:D008881 |
Migraine Disorders |
|
Valproic Acid |
3.03 | 18765137 18803445 |
MESH:D052016 |
Mucositis |
|
Methotrexate |
5.05 | 17488658 |
MESH:D009135 |
Muscular Diseases |
|
pirinixic acid |
3.28 | 16239165 |
MESH:D009139 |
Musculoskeletal Abnormalities |
|
Valproic Acid |
3.82 | 8888407 |
MESH:D009181 |
Mycoses |
|
Amiodarone |
4.67 | 12754197 17974566 |
MESH:D009190 |
Myelodysplastic Syndromes |
|
Valproic Acid |
3.03 | 17596541 |
MESH:D009203 |
Myocardial Infarction |
|
pirinixic acid |
5.41 | 19151258 |
MESH:D009203 |
Myocardial Infarction |
|
Quercetin |
5.41 | 19595682 |
MESH:D017202 |
Myocardial Ischemia |
|
Tetrachlorodibenzodioxin |
2.84 | 12213967 |
MESH:D015428 |
Myocardial Reperfusion Injury |
|
pirinixic acid |
7.86 | 16411023 |
MESH:D015428 |
Myocardial Reperfusion Injury |
|
Quercetin |
7.86 | 19207477 |
MESH:D009336 |
Necrosis |
|
2,6-dinitrotoluene |
9.92 | 18551238 7678174 |
MESH:D009336 |
Necrosis |
|
Trinitrotoluene |
9.92 | 18551238 |
MESH:D009362 |
Neoplasm Metastasis |
|
capecitabine |
4.04 | 12972520 |
MESH:D009369 |
Neoplasms |
|
capecitabine |
7.82 | 16374040 |
MESH:D009369 |
Neoplasms |
|
pirinixic acid |
7.82 | 17405874 |
MESH:D009369 |
Neoplasms |
|
Quercetin |
7.82 | 15185748 |
MESH:D009402 |
Nephrosis, Lipoid |
|
Cyclosporine |
4.21 | 17954296 |
MESH:D009404 |
Nephrotic Syndrome |
|
Cyclosporine |
3.09 | 19348381 18481113 |
MESH:D009421 |
Nervous System Malformations |
|
Tetrachlorodibenzodioxin |
3.00 | 14600291 |
MESH:D009436 |
Neural Tube Defects |
|
Valproic Acid |
2.98 | 16359493 8888407 |
MESH:D019636 |
Neurodegenerative Diseases |
|
Acetaminophen |
2.69 | 18514411 |
MESH:D020078 |
Neurogenic Inflammation |
|
Quercetin |
4.15 | 17929310 |
MESH:D052556 |
Niemann-Pick Disease, Type C |
|
perfluorooctanoic acid |
4.73 | 9802331 |
MESH:D009765 |
Obesity |
|
Dietary Fats |
4.24 | 19632207 21332399 20518802 20132043 18674790 11836018 16723640 17217161 18457598 |
MESH:D009765 |
Obesity |
|
pirinixic acid |
4.24 | 20558911 |
MESH:D009784 |
Occupational Diseases |
|
2,6-dinitrotoluene |
14.13 | 16049721 |
MESH:D009784 |
Occupational Diseases |
|
4-amino-2,6-dinitrotoluene |
14.13 | 14694615 |
MESH:D009784 |
Occupational Diseases |
|
Trinitrotoluene |
14.13 | 14694615 12819281 17852074 |
MESH:D015663 |
Osteoporosis, Postmenopausal |
|
Quercetin |
4.01 | 19495926 |
MESH:D010051 |
Ovarian Neoplasms |
|
Quercetin |
2.66 | 19005980 |
MESH:D010146 |
Pain |
|
Acetaminophen |
2.21 | 16870215 |
MESH:D010190 |
Pancreatic Neoplasms |
|
Quercetin |
2.77 | 16965848 |
MESH:D010382 |
Peliosis Hepatis |
|
Tetrachlorodibenzodioxin |
4.02 | 12520081 |
MESH:D016491 |
Peripheral Vascular Diseases |
|
Cadmium |
5.15 | 15687053 |
MESH:C536663 |
Peroxisomal bifunctional enzyme deficiency |
marker/mechanism |
|
| |
MESH:D017119 |
Porphyria Cutanea Tarda |
|
Tetrachlorodibenzodioxin |
3.34 | 18163543 |
MESH:D011230 |
Precancerous Conditions |
|
Cyclosporine |
8.46 | 12371664 |
MESH:D011230 |
Precancerous Conditions |
|
Quercetin |
8.46 | 19056647 |
MESH:D011297 |
Prenatal Exposure Delayed Effects |
|
perfluorooctanoic acid |
14.97 | 17132714 |
MESH:D011297 |
Prenatal Exposure Delayed Effects |
|
Tetrachlorodibenzodioxin |
14.97 | 11896295 11399792 11222880 11118676 |
MESH:D011297 |
Prenatal Exposure Delayed Effects |
|
Valproic Acid |
14.97 | 20603192 |
MESH:D011471 |
Prostatic Neoplasms |
|
Cadmium |
3.76 | 17075824 |
MESH:D011471 |
Prostatic Neoplasms |
|
Quercetin |
3.76 | 17292933 14715546 |
MESH:D019310 |
Pseudolymphoma |
|
Valproic Acid |
4.31 | 12752131 11422049 |
MESH:D011565 |
Psoriasis |
|
Cyclosporine |
5.64 | 16882103 |
MESH:D011565 |
Psoriasis |
|
Methotrexate |
5.64 | 17410198 |
MESH:D011658 |
Pulmonary Fibrosis |
|
Amiodarone |
2.77 | 12490602 11597910 12832656 |
MESH:D051437 |
Renal Insufficiency |
|
Methotrexate |
4.49 | 17352296 |
MESH:D015427 |
Reperfusion Injury |
|
pirinixic acid |
2.28 | 19058328 |
MESH:D015619 |
Respiratory System Abnormalities |
|
Tetrachlorodibenzodioxin |
3.62 | 18990726 |
MESH:D012208 |
Rhabdomyosarcoma |
|
Valproic Acid |
3.96 | 19155313 |
MESH:D012554 |
Schistosomiasis japonica |
|
Quercetin |
5.31 | 16862918 |
MESH:D012559 |
Schizophrenia |
|
Valproic Acid |
2.04 | 19110320 15737665 |
MESH:D012640 |
Seizures |
|
2,6-dinitrotoluene |
9.05 | 18551238 |
MESH:D012640 |
Seizures |
|
Trinitrotoluene |
9.05 | 18551238 |
MESH:D012640 |
Seizures |
|
Valproic Acid |
9.05 | 15475178 11738929 14763951 16876388 3137016 11044598 1511512 17978042 |
OMIM:609620 |
SHORT QT SYNDROME 1 |
|
Amiodarone |
4.85 | 18724381 |
MESH:D012878 |
Skin Neoplasms |
|
Tetrachlorodibenzodioxin |
1.94 | 16192470 |
MESH:D016135 |
Spinal Dysraphism |
|
Valproic Acid |
3.61 | 19490988 |
MESH:D013163 |
Splenomegaly |
|
Trinitrotoluene |
4.98 | 15817613 |
MESH:D013226 |
Status Epilepticus |
|
Valproic Acid |
4.31 | 12833885 |
MESH:D013274 |
Stomach Neoplasms |
|
S 1 (combination) |
3.36 | 16557585 18506536 18553229 |
MESH:D013276 |
Stomach Ulcer |
|
Amiodarone |
3.12 | 18087811 |
MESH:D013576 |
Syndactyly |
|
Methotrexate |
4.81 | 9562676 |
MESH:D013610 |
Tachycardia |
|
Amiodarone |
4.07 | 11238279 |
MESH:D017180 |
Tachycardia, Ventricular |
|
Amiodarone |
3.97 | 19225199 |
MESH:D013959 |
Thyroid Diseases |
|
Amiodarone |
11.28 | 19731979 |
MESH:D013959 |
Thyroid Diseases |
|
Tetrachlorodibenzodioxin |
11.28 | 12697716 |
MESH:D013971 |
Thyrotoxicosis |
|
Amiodarone |
4.63 | 18020914 19584973 |
MESH:D016171 |
Torsades de Pointes |
|
Amiodarone |
3.96 | 11989578 17467628 |
MESH:D014178 |
Translocation, Genetic |
|
Valproic Acid |
5.00 | 17262798 |
MESH:D020194 |
Unverricht-Lundborg Syndrome |
|
Valproic Acid |
4.29 | 3119515 |
MESH:D001749 |
Urinary Bladder Neoplasms |
|
2,6-dinitrotoluene |
4.90 | 16049721 |
MESH:D001749 |
Urinary Bladder Neoplasms |
|
Quercetin |
4.90 | 16720314 |
MESH:D014564 |
Urogenital Abnormalities |
|
Valproic Acid |
4.42 | 8888407 |
MESH:D014571 |
Urologic Neoplasms |
|
2,6-dinitrotoluene |
4.09 | 10091137 |
MESH:D014581 |
Urticaria |
|
Acetaminophen |
2.77 | 10982225 |
MESH:D014605 |
Uveitis |
|
Cyclosporine |
3.75 | 1336536 |
MESH:D054079 |
Vascular Malformations |
|
Tetrachlorodibenzodioxin |
4.36 | 12125929 |
MESH:D014689 |
Venous Insufficiency |
|
coumarin |
5.55 | 12708602 |
MESH:D019282 |
Wasting Syndrome |
|
Tetrachlorodibenzodioxin |
4.02 | 15886252 |
MESH:D015430 |
Weight Gain |
|
Dietary Fats |
3.55 | 16723640 |
MESH:D014985 |
Xerophthalmia |
|
Cyclosporine |
4.21 | 17120751 |